NeoGenomics Settles False Claims Allegations for $9.8 Million

The government’s investigation focused on two primary practices: providing laboratory consulting services to 28 providers at rates below fair market value and paying variable, referral-based compensation to independent consultants tasked with identifying potential test sources. While the settlement marks a financial resolution, it does not constitute an admission of liability from NeoGenomics, nor does it confirm the validity of the government’s specific claims.

NeoGenomics initiated the process by self-disclosing the potential misconduct to the Department of Health and Human Services in 2021. Federal authorities credited the company for its cooperation, noting that the firm terminated the disputed consulting agreements and dismissed employees involved in the practice. Having previously set aside $11.2 million to address the legal exposure, the company remains within its anticipated financial boundaries for the resolution.